Mehrdad A. Estiar

1.5k total citations
54 papers, 880 citations indexed

About

Mehrdad A. Estiar is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mehrdad A. Estiar has authored 54 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mehrdad A. Estiar's work include Hereditary Neurological Disorders (10 papers), Neurological diseases and metabolism (8 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Mehrdad A. Estiar is often cited by papers focused on Hereditary Neurological Disorders (10 papers), Neurological diseases and metabolism (8 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Mehrdad A. Estiar collaborates with scholars based in Iran, Canada and United States. Mehrdad A. Estiar's co-authors include Ebrahim Sakhinia, Mahdiar Taheri, Amir Reza Aref, E.A. Mohamed, Mohammad Sadegh Amiri, Mahshid Hashemkhani, Navid Solati, Amir Ghasemi, Mahdi Karimi and Michael R. Hamblin and has published in prestigious journals such as Gene, European Journal of Pharmacology and Movement Disorders.

In The Last Decade

Mehrdad A. Estiar

53 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehrdad A. Estiar Iran 16 362 145 133 132 120 54 880
Yumin Oh United States 18 485 1.3× 129 0.9× 78 0.6× 53 0.4× 79 0.7× 29 1.2k
Martina Bartolucci Italy 22 620 1.7× 198 1.4× 131 1.0× 60 0.5× 45 0.4× 66 1.2k
Shiyu Yang China 12 484 1.3× 121 0.8× 44 0.3× 90 0.7× 48 0.4× 36 880
Benoît Thezé France 17 306 0.8× 150 1.0× 38 0.3× 87 0.7× 114 0.9× 25 948
Hiroya Kuwahara Japan 15 510 1.4× 87 0.6× 87 0.7× 41 0.3× 72 0.6× 62 926
Qiang Cai China 16 320 0.9× 96 0.7× 157 1.2× 45 0.3× 74 0.6× 56 792
Tomokazu Hasegawa Japan 21 760 2.1× 112 0.8× 114 0.9× 105 0.8× 266 2.2× 73 1.4k
Jun‐yi Zhu China 20 731 2.0× 115 0.8× 177 1.3× 32 0.2× 103 0.9× 55 1.3k
Linhao You China 16 313 0.9× 127 0.9× 130 1.0× 69 0.5× 47 0.4× 20 930
Elizabeth Garcia United States 12 451 1.2× 227 1.6× 113 0.8× 33 0.3× 172 1.4× 21 996

Countries citing papers authored by Mehrdad A. Estiar

Since Specialization
Citations

This map shows the geographic impact of Mehrdad A. Estiar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad A. Estiar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad A. Estiar more than expected).

Fields of papers citing papers by Mehrdad A. Estiar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehrdad A. Estiar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad A. Estiar. The network helps show where Mehrdad A. Estiar may publish in the future.

Co-authorship network of co-authors of Mehrdad A. Estiar

This figure shows the co-authorship network connecting the top 25 collaborators of Mehrdad A. Estiar. A scholar is included among the top collaborators of Mehrdad A. Estiar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehrdad A. Estiar. Mehrdad A. Estiar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Estiar, Mehrdad A., et al.. (2025). Hereditary Spastic Paraplegia in Alberta: Lessons from a Well‐Defined Cohort Including the Indigenous Population. Movement Disorders Clinical Practice. 12(9). 1346–1356.
2.
Barnérias, Christine, Mehrdad A. Estiar, Claire Ewenczyk, et al.. (2024). From spastic paraplegia to infantile neurodegenerative disorder: Expanding the phenotypic spectrum associated with biallelic SPAST variants. European Journal of Neurology. 32(1). e70025–e70025. 2 indexed citations
3.
Estiar, Mehrdad A., Simon Veyron, Kheireddin Mufti, et al.. (2022). Genetic, structural and clinical analysis of spastic paraplegia 4. Parkinsonism & Related Disorders. 98. 62–69. 14 indexed citations
4.
Yu, Eric, Aditya Ambati, Lynne Krohn, et al.. (2021). Fine mapping of the HLA locus in Parkinson’s disease in Europeans. npj Parkinson s Disease. 7(1). 84–84. 34 indexed citations
5.
Estiar, Mehrdad A., Konstantin Senkevich, Eric Yu, et al.. (2021). Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson's Disease. Movement Disorders. 36(8). 1967–1972. 7 indexed citations
6.
Estiar, Mehrdad A., Eric Yu, Jay P. Ross, et al.. (2021). Evidence for Non‐Mendelian Inheritance in Spastic Paraplegia 7. Movement Disorders. 36(7). 1664–1675. 14 indexed citations
7.
Yoon, Grace, Mehrdad A. Estiar, Simon Veyron, et al.. (2021). GCH1 mutations in hereditary spastic paraplegia. Clinical Genetics. 100(1). 51–58. 5 indexed citations
8.
Beaudin, Marie, et al.. (2021). Genetic and Epidemiological Study of Adult Ataxia and Spastic Paraplegia in Eastern Quebec. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(5). 655–665. 4 indexed citations
9.
Rezaei, Omidvar, et al.. (2021). Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease. European Journal of Pharmacology. 896. 173914–173914. 27 indexed citations
10.
Suchowersky, Oksana, et al.. (2021). Hereditary spastic paraplegia initially diagnosed as cerebral palsy. Clinical Parkinsonism & Related Disorders. 5. 100114–100114. 6 indexed citations
11.
Yu, Eric, Uladzislau Rudakou, Lynne Krohn, et al.. (2020). Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease. Movement Disorders. 36(1). 178–187. 29 indexed citations
12.
Estiar, Mehrdad A., Etienne Léveillé, Dan Spiegelman, et al.. (2020). Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype. Molecular Genetics & Genomic Medicine. 8(3). e1052–e1052. 18 indexed citations
13.
Hashemzadeh, Shahriar, et al.. (2016). Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker. Oncology Letters. 12(6). 5335–5343. 23 indexed citations
14.
Salmaninejad, Arash, et al.. (2016). HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method. Oncology Letters. 12(6). 4651–4658. 20 indexed citations
15.
Khabbazi, Alireza, et al.. (2016). Molecular Analysis of MEFV Gene Polymorphisms and Mutations in Iranian Azeri Patients with Rheumatoid Arthritis.. PubMed. 45(10). 1383–1385. 2 indexed citations
16.
Bahrami, Tayyeb, et al.. (2016). The molecular signature of breast cancer metastasis to bone. Anti-Cancer Drugs. 27(9). 824–831. 4 indexed citations
17.
Estiar, Mehrdad A., Rezvan Esmaeili, Ali Zare, et al.. (2016). High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer. Clinical and Experimental Medicine. 17(4). 547–553. 9 indexed citations
18.
Karimi, Mahdi, Navid Solati, Mohammad Sadegh Amiri, et al.. (2015). Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle. Expert Opinion on Drug Delivery. 12(7). 1071–1087. 98 indexed citations
19.
Hashemzadeh, Shahryar, et al.. (2014). Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer. Medical Oncology. 31(10). 237–237. 14 indexed citations
20.
Fakhrjou, Ashraf, et al.. (2013). Bcl-2 Gene Expression in Human Breast Cancers in Iran. Asian Pacific Journal of Cancer Prevention. 14(7). 4209–4214. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yumin Oh Breakdown of academic impact, for papers by Martina Bartolucci Breakdown of academic impact, for papers by Shiyu Yang Breakdown of academic impact, for papers by Benoît Thezé Breakdown of academic impact, for papers by Hiroya Kuwahara Breakdown of academic impact, for papers by Qiang Cai Breakdown of academic impact, for papers by Tomokazu Hasegawa Breakdown of academic impact, for papers by Jun‐yi Zhu Breakdown of academic impact, for papers by Linhao You Breakdown of academic impact, for papers by Elizabeth Garcia
Rankless by CCL
2026